Clinical and Prognostic Significance of RhoA and RhoC Gene Expression in Esophageal Squamous Cell Carcinoma
暂无分享,去创建一个
H. Kuwano | H. Kato | L. Faried | A. Faried | N. Usman | Nurhayat Usman | Leri S. Faried
[1] J. Ouyang,et al. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[2] S. Sebti,et al. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA. , 2006, Life sciences.
[3] S. Merajver,et al. RhoC GTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinomas of the Head and Neck , 2006, Clinical Cancer Research.
[4] H. Kuwano,et al. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo. , 2006, European journal of cancer.
[5] K. Lawler,et al. Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner. , 2006, American journal of physiology. Cell physiology.
[6] Sofia D. Merajver,et al. RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast , 2005, Breast Cancer Research and Treatment.
[7] H. Kuwano,et al. Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[8] M. S. Miller,et al. Determination of murine fetal Cyp1a1 and 1b1 expression by real-time fluorescence reverse transcription-polymerase chain reaction. , 2004, Toxicology and applied pharmacology.
[9] L-Y Yang,et al. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis , 2004, British Journal of Cancer.
[10] S. Merajver,et al. Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells. , 2003, Molecular cancer therapeutics.
[11] Kyoko Arai,et al. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[12] T. Nikaido,et al. Up-Regulation of Small GTPases, RhoA and RhoC, Is Associated with Tumor Progression in Ovarian Carcinoma , 2003, Laboratory Investigation.
[13] Min Wu,et al. Gene expression profiles at different stages of human esophageal squamous cell carcinoma. , 2003, World journal of gastroenterology.
[14] S. Merajver,et al. Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor. , 2002, Molecular cancer therapeutics.
[15] H. Shirasawa,et al. Alteration of integrin expression relates to malignant progression of human papillomavirus-immortalized esophageal keratinocytes. , 2002, Cancer letters.
[16] S. Merajver,et al. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. , 2002, The American journal of pathology.
[17] T. Kamai,et al. Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour , 2001, BJU international.
[18] M. Iannettoni,et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] S. Merajver,et al. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. , 2000, Cancer research.
[20] Eric S. Lander,et al. Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.
[21] F. Imamura,et al. Y‐27632, an Inhibitor of Rho‐associated Protein Kinase, Suppresses Tumor Cell Invasion via Regulation of Focal Adhesion and Focal Adhesion Kinase , 2000, Japanese journal of cancer research : Gann.
[22] C. Myers,et al. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. , 2000, Biochemical and biophysical research communications.
[23] B. Kaina,et al. Rho GTPases are over‐expressed in human tumors , 1999, International journal of cancer.
[24] Shuh Narumiya,et al. An essential part for Rho–associated kinase in the transcellular invasion of tumor cells , 1999, Nature Medicine.
[25] L. Peso,et al. Rho proteins induce metastatic properties in vivo , 1997, Oncogene.
[26] T. Walsh,et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.
[27] M. Coleman,et al. Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.
[28] C J Marshall,et al. Post-translational modifications of p21rho proteins. , 1992, The Journal of biological chemistry.
[29] H. Kanazawa,et al. A case of esophageal carcinoma metastatic to the mandible and characterization of two cell lines (T. T and T. Tn) established from the oral tumor , 1990 .
[30] T. Kuroki,et al. Molecular and cellular features of esophageal cancer cells , 2005, Journal of Cancer Research and Clinical Oncology.
[31] Zhenbiao Yang,et al. RHO Gtpases and the Actin Cytoskeleton , 2000 .
[32] S. Narumiya,et al. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. , 1998, British Journal of Cancer.
[33] P. Casey,et al. Protein prenylation: molecular mechanisms and functional consequences. , 1996, Annual review of biochemistry.
[34] Y. Matsuzawa,et al. Hepatocellular Carcinoma (hcc) Causes Death in Patients with Cirrhosis and Is One of the Most Prevalent Malignant Tumours Effect of Pravastatin on Survival in Patients with Advanced Hepatocellular Carcinoma. a Randomized Controlled Trial , 2022 .